Home Conference Coverage

Conference Coverage

General images of ESMO 2019 Congress being held in Barcelona, Spain, September 27 - October 1, 2019. Courtesy European Society for Medical Oncology (ESMO). Used with Permission.

ESMO 2019: New Approach in Treatment of Cholangiocarcinoma Shows Clinical Benefit

Peter Hofland, Ph.D -
General images of ESMO 2019 Congress being held in Barcelona, Spain, September 27 - October 1, 2019. Courtesy European Society for Medical Oncology (ESMO). Used with Permission.

ESMO 2019: Sacituzumab Govitecan in Metastatic Urothelial Cancer and Breast Cancer

Peter Hofland, Ph.D -
General images of ESMO 2019 Congress being held in Barcelona, Spain, September 27 - October 1, 2019. Courtesy European Society for Medical Oncology (ESMO). Used with Permission.

ESMO 2019: Target Engagement in Phase I Clinical Trial with First-in-Class...

Peter Hofland, Ph.D -
General images of ESMO 2019 Congress being held in Barcelona, Spain, September 27 - October 1, 2019. Courtesy European Society for Medical Oncology (ESMO). Used with Permission.

ESMO 2019: FORWARD I Study Evaluating Mirvetuximab Soravtansine Did Not Meet...

Peter Hofland, Ph.D -
General images of ESMO 2019 Congress being held in Barcelona, Spain, September 27 - October 1, 2019. Courtesy European Society for Medical Oncology (ESMO). Used with Permission.

New Blood Test Capable of Accurately Detecting and Localizing more than...

Peter Hofland, Ph.D -
General images of ESMO 2019 Congress being held in Barcelona, Spain, September 27 - October 1, 2019. Courtesy European Society for Medical Oncology (ESMO). Used with Permission.

ESMO 2019: Enfortumab Vedotin + Pembrolizumab Shows High ORR in Bladder...

Peter Hofland, Ph.D -
General images of ESMO 2019 Congress being held in Barcelona, Spain, September 27 - October 1, 2019. Courtesy European Society for Medical Oncology (ESMO). Used with Permission.

ESMO 2019: Radiotherapy after Surgery Could be Omitted or Delayed in...

Peter Hofland, Ph.D -
General images of ESMO 2019 Congress being held in Barcelona, Spain, September 27 - October 1, 2019. Courtesy European Society for Medical Oncology (ESMO). Used with Permission.

ESMO 2019: Positive Results of Olaparib + Bevacizumab in Newly-Diagnosed Advanced...

Peter Hofland, Ph.D -

ESMO 2019: Advanced Hepatocellular Carcinoma and the Clinical Benefit of First-Line...

Peter Hofland, Ph.D -
European Society for Medical Oncology (ESMO) 2019, held Sep 27, 2019 - Oct 1, 2019 in the Fira Barcelona Gran Via, L'Hospitalet de Llobregat, Spain

ESMO 2019: Are Novel Anti-cancer Drugs Worth A Higher Price?

Danielle Garcia -
123...26Page 1 of 26

LATEST

© 2019 Sunvalley Communication, LLC. All Rights Reserved.